Analysis Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token instead of funding its own drug by admin July 31, 2026 by admin July 31, 2026 Enlivex, a Nasdaq-listed biotechnology company, is asking shareholders to authorize up to $800 million of… Read more 0 FacebookTwitterPinterestEmail
